# Spironolactone for Reducing Proteinuria in Diabetic Nephropathy

> **NCT00498537** · NA · COMPLETED · sponsor: **US Department of Veterans Affairs** · enrollment: 30 (actual)

## Conditions studied

- Diabetic Nephropathy

## Interventions

- **DRUG:** spironolactone

## Key facts

- **NCT ID:** NCT00498537
- **Lead sponsor:** US Department of Veterans Affairs
- **Sponsor class:** FED
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-01
- **Primary completion:** 2005-12
- **Final completion:** 2006-06
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2008-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00498537

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00498537, "Spironolactone for Reducing Proteinuria in Diabetic Nephropathy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00498537. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*